» Articles » PMID: 39997475

Cardiovascular Outcomes in Hospitalized Patients with COVID-19: Does Age Really Matter?

Abstract

Background: An advanced age elevates risk for COVID-19-related cardiovascular complications and mortality. This study analyzes cardiovascular comorbidities and outcomes in hospitalized COVID-19 patients across age groups to assess its impact.

Methods: The CARDIO COVID 19-20 registry is a prospective, multicenter cohort study of hospitalized SARS-CoV-2 patients across 44 institutions in 14 Latin American countries. Patients were categorized into four age groups, Group 1: under 40 years, Group 2: 40 to 64 years, Group 3: 65 to 79 years, and Group 4: 80 years or older.

Results: A total of 3260 patients were included. A total of 36.8% were women, and key comorbidities included overweight/obesity (49.7% [G1: 48.9%, G2: 56.3%, G3: 45.6%, G4: 32.7%]), and hypertension (49% [G1: 11.3%, G2: 40.3%, G3: 67.9%, G4: 80.4%]). Primary cardiovascular complications during hospitalization were arrhythmias (9.1% [G1: 3.4%, G2: 6.1%, G3: 14.9%, G4: 12.9%]), and acute heart failure (8.5% [G1: 3.6%, G2: 6.1%, G3: 12.1%, and G4: 15.2%]). In our cohort, 53.5% of the patients were admitted to the intensive care unit (G1: 49.2%, G2: 57%, G3: 55.3%, G4: 38.3%). In-hospital mortality rose significantly in patients aged 65 and older; G3: 334 (34.7%) and G4: 156 (45.6%) ( value: <0.001).

Conclusions: In Latin American COVID-19 patients, older age correlates with more comorbidities, cardiovascular complications, and higher in-hospital and 30-day mortality, indicating age as an independent mortality factor.

References
1.
Ko J, Danielson M, Town M, Derado G, Greenlund K, Kirley P . Risk Factors for Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization: COVID-19-Associated Hospitalization Surveillance Network and Behavioral Risk Factor Surveillance System. Clin Infect Dis. 2020; 72(11):e695-e703. PMC: 7543371. DOI: 10.1093/cid/ciaa1419. View

2.
Giabicani M, Le Terrier C, Poncet A, Guidet B, Rigaud J, Quenot J . Limitation of life-sustaining therapies in critically ill patients with COVID-19: a descriptive epidemiological investigation from the COVID-ICU study. Crit Care. 2023; 27(1):103. PMC: 10006561. DOI: 10.1186/s13054-023-04349-1. View

3.
Guo T, Fan Y, Chen M, Wu X, Zhang L, He T . Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(7):811-818. PMC: 7101506. DOI: 10.1001/jamacardio.2020.1017. View

4.
Song J, Park D, Cha J, Seok H, Kim J, Park J . Clinical course and risk factors of fatal adverse outcomes in COVID-19 patients in Korea: a nationwide retrospective cohort study. Sci Rep. 2021; 11(1):10066. PMC: 8115137. DOI: 10.1038/s41598-021-89548-y. View

5.
Wang W, Wang C, Wang S, Cheng-Chung Wei J . Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: A retrospective cohort study from the TriNetX US collaborative networks. EClinicalMedicine. 2022; 53:101619. PMC: 9366236. DOI: 10.1016/j.eclinm.2022.101619. View